X0306 4 2022-01-11 0 0001868734 CinCor Pharma, Inc. CINC 0001574139 Sofinnova Partners SAS 7-11 BOULEVARD HAUSSMANN PARIS I0 75009 FRANCE 0 0 1 0 0001849915 Sofinnova Capital IX 7-11 BOULEVARD HAUSSMANN PARIS I0 75009 FRANCE 0 0 1 0 Common Stock 2022-01-11 4 C 0 3867646 A 3867646 I By Sofinnova Capital IX Common Stock 2022-01-11 4 P 0 220000 16.00 A 4087646 I By Sofinnova Capital IX Series A Preferred Stock 2022-01-11 4 C 0 9999999 0.00 D Common Stock 2941176 0 I By Sofinnova Capital IX Series B Preferred Stock 2022-01-11 4 C 0 3150000 0.00 D Common Stock 926470 0 I By Sofinnova Capital IX Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a 3.4:1 basis, and had no expiration date. The shares are directly held by Sofinnova Capital IX ("SC IX"). Sofinnova Partners SAS ("Sofinnova Partners") is the management company of SC IX and may be deemed to share voting and investment power over the shares held by SC IX. Sofinnova Partners disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein. Sofinnova Partners SAS, By /s/ Monique Saulnier, Managing Partner 2022-01-13 Sofinnova Capital IX, By: Sofinnova Partners SAS, its management company, By /s/ Monique Saulnier, Managing Partner 2022-01-13